Literature DB >> 2948971

Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy.

A K Ghosh, A I Spriggs, M Charnock.   

Abstract

Specimens of peritoneal fluid or peritoneal washings from a series of 106 patients who had had laparotomy or laparoscopy for gynaecological complaints were studied "blind" by conventional cytology and immunocytochemical staining. The antibodies used were Ca 1 or Ca 2, anti-CEA, and HMFG-2 or E29. All these are directed against epithelial antigens and are expressed on most malignant epithelial cells and weakly or not at all on mesothelial cells. It was hoped that these reactions would confirm diagnoses made by conventional cytology and possibly show malignant cells which had not already been identified. Of 28 patients with malignant disease (chosen to exclude any with frank ascites), eight gave positive immunochemical reactions, only four having been reported positive from conventional examination. Of 77 patients without malignant disease, HMFG-2 or E29 gave positive reactions in seven, Ca 1 or Ca 2 in two, and anti-CEA in two (reactions with plasma cells being disregarded). Some misleading reactions were probably due to endometrial cells. It was concluded that the antibodies used in this study are not sufficiently specific or sensitive to allow immunocytochemical staining to replace conventional cytological diagnosis but are a useful supplementary aid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948971      PMCID: PMC1140798          DOI: 10.1136/jcp.39.12.1335

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Cytology of the pelvic peritoneal cavity in benign and malignant disease.

Authors:  C C MARCUS
Journal:  Obstet Gynecol       Date:  1962-12       Impact factor: 7.661

2.  A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.

Authors:  J C Woods; A I Spriggs; H Harris; J O McGee
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

3.  The prognostic value of peritoneal cytology in gynecologic malignant disease.

Authors:  W T Creasman; F Rutledge
Journal:  Am J Obstet Gynecol       Date:  1971-07-15       Impact factor: 8.661

4.  Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.

Authors:  M E Bramwell; A K Ghosh; W D Smith; G Wiseman; A I Spriggs; H Harris
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

7.  Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.

Authors:  A A Epenetos; G Canti; J Taylor-Papadimitriou; M Curling; W F Bodmer
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

8.  Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis.

Authors:  J L Covell; J B Carry; P S Feldman
Journal:  Acta Cytol       Date:  1985 May-Jun       Impact factor: 2.319

9.  Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls.

Authors:  E Ravinsky
Journal:  Acta Cytol       Date:  1986 Jan-Feb       Impact factor: 2.319

10.  Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry.

Authors:  J Cordell; T C Richardson; K A Pulford; A K Ghosh; K C Gatter; E Heyderman; D Y Mason
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.